PH12016500509A1 - Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins - Google Patents

Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins

Info

Publication number
PH12016500509A1
PH12016500509A1 PH12016500509A PH12016500509A PH12016500509A1 PH 12016500509 A1 PH12016500509 A1 PH 12016500509A1 PH 12016500509 A PH12016500509 A PH 12016500509A PH 12016500509 A PH12016500509 A PH 12016500509A PH 12016500509 A1 PH12016500509 A1 PH 12016500509A1
Authority
PH
Philippines
Prior art keywords
compositions
clotting factor
proteins
recombinant human
human clotting
Prior art date
Application number
PH12016500509A
Inventor
Jankowski Michael Anthony
Keith A Johnson
Piacenza Wendy Carol
Jason C Rouse
Shamashkin Michael
Sharpe Penelope Jane
Switzer Mary Beth
Stacey B Weston
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2014/064564 external-priority patent/WO2015044836A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of PH12016500509A1 publication Critical patent/PH12016500509A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
PH12016500509A 2014-09-16 2016-03-15 Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins PH12016500509A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/064564 WO2015044836A1 (en) 2013-09-24 2014-09-16 Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
US201461881834P 2014-09-24 2014-09-24

Publications (1)

Publication Number Publication Date
PH12016500509A1 true PH12016500509A1 (en) 2016-06-13

Family

ID=57939764

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500509A PH12016500509A1 (en) 2014-09-16 2016-03-15 Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins

Country Status (1)

Country Link
PH (1) PH12016500509A1 (en)

Similar Documents

Publication Publication Date Title
AU201612779S (en) Oral care implement
AU201612764S (en) Oral care implement
MY182667A (en) Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alphalactalbumin protein
AU201612818S (en) Oral care implement
HRP20192173T8 (en) Expression of recombinant proteins in trichoplusia ni pupae
SI3197472T1 (en) Recombinant phe-free proteins for use in the treatment of phenylketonuria
AU201612579S (en) Oral care implement
MX2020000083A (en) Treatment of coagulation disease by administration of recombinant vwf.
IL279396A (en) Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
MX2018000570A (en) Novel trypsin isoforms and their use.
ZA201803551B (en) Personal care composition comprising taurine, arginine, glycine
IL247551A0 (en) Dry-powder peptide medicament
AU201612882S (en) Oral care implement
SG10201912768YA (en) Truncated von willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder
PH12018550097A1 (en) Infant formula comprising human milk peptides
MX2020013410A (en) Prohemostatic proteins for the treatment of bleeding.
PH12016500509A1 (en) Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
MX2015007625A (en) Sealant compositions.
EP3359145A4 (en) Recombinant prothrombin analogues and uses thereof
PH12016501608A1 (en) Peptides and methods of use
EP3229821A4 (en) Collagenase-derived peptides promote tissue regeneration and wound healing
EP3129408A4 (en) Half-life extended factor fviia protein for prevention and treatment of bleeding and dosing regimens therefor
FR3049867B1 (en) HEMOSTATIC AND HEALING COMPOSITION